[go: up one dir, main page]

GB0520365D0 - Crystal structure of CD44 and its use - Google Patents

Crystal structure of CD44 and its use

Info

Publication number
GB0520365D0
GB0520365D0 GBGB0520365.8A GB0520365A GB0520365D0 GB 0520365 D0 GB0520365 D0 GB 0520365D0 GB 0520365 A GB0520365 A GB 0520365A GB 0520365 D0 GB0520365 D0 GB 0520365D0
Authority
GB
United Kingdom
Prior art keywords
crystal structure
crystal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0520365.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Priority to GBGB0520365.8A priority Critical patent/GB0520365D0/en
Publication of GB0520365D0 publication Critical patent/GB0520365D0/en
Priority to PCT/GB2006/003734 priority patent/WO2007039761A2/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70585—CD44
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70585—CD44
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
GBGB0520365.8A 2005-10-06 2005-10-06 Crystal structure of CD44 and its use Ceased GB0520365D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0520365.8A GB0520365D0 (en) 2005-10-06 2005-10-06 Crystal structure of CD44 and its use
PCT/GB2006/003734 WO2007039761A2 (en) 2005-10-06 2006-10-06 Crystal structure of cd44 and its use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0520365.8A GB0520365D0 (en) 2005-10-06 2005-10-06 Crystal structure of CD44 and its use

Publications (1)

Publication Number Publication Date
GB0520365D0 true GB0520365D0 (en) 2005-11-16

Family

ID=35429941

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0520365.8A Ceased GB0520365D0 (en) 2005-10-06 2005-10-06 Crystal structure of CD44 and its use

Country Status (2)

Country Link
GB (1) GB0520365D0 (en)
WO (1) WO2007039761A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012519710A (en) * 2009-03-06 2012-08-30 アングストロム プハルマセウトイカルス インコーポレイテッド Compositions and methods for modulating cell migration
CA2795698A1 (en) 2010-03-05 2011-09-09 Angstrom Pharmaceuticals, Inc. Modulation of intracellular signaling
EP4424711A3 (en) 2020-05-19 2024-10-23 Institut Curie Methods for the diagnosis and treatment of cytokine release syndrome

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003094843A2 (en) * 2002-05-10 2003-11-20 Incyte Corporation Cell adhesion and extracellular matrix proteins

Also Published As

Publication number Publication date
WO2007039761A3 (en) 2007-06-21
WO2007039761A2 (en) 2007-04-12

Similar Documents

Publication Publication Date Title
IL188078A0 (en) Nano-ionic liquids and methods of use
ZA200802501B (en) Indenoisoquinolinone analogs and methods of use thereof
EP2021555A4 (en) Structural element and methods of use thereof
EP1951680A4 (en) Novel 2-aminopyrimidinone derivatives and their use
ZA200710153B (en) Tigecycline and methods of preparation
IL185309A0 (en) Isoqunoline compounds and methods of use thereof
ZA200805837B (en) VIP fragments and methods of use
IL190039A0 (en) Supercritical flat panel collector and methods of use
IL189252A0 (en) Dihydroxyanthraquinones and their use
EP1951682A4 (en) Novel 2-aminopyrimidinone or 2-aminopyridinone derivatives and their use
GB2440843B (en) Liquid sealant and methods of use
PT2380573E (en) Eslicarbazepine acetate and methods of use
EP1951681A4 (en) Novel 2-aminopyrimidine derivatives and their use
DK2392335T3 (en) Use of 24-norUDCA
EP1931385A4 (en) (s)-6-methyloxaalkyl exemestane compounds and related methods of use
GB0421538D0 (en) Liquid crystal structure
GB0520365D0 (en) Crystal structure of CD44 and its use
EP1709445A4 (en) Itpks as modifiers of the igfr pathway and methods of use
PL1902047T3 (en) Carboxamide compound and use of the same
GB0508356D0 (en) Materials and methods relating to the diagnosis of cancer
AU2007297869A8 (en) Crystal structure of CRIg and C3b: CRIg complex
GB0715284D0 (en) Crystal structure of ampk and uses thereof
TWI339679B (en) Liquid crystal and liquid crystal display
TWI366941B (en) Electrolyte containing oxocarbons and its use
ZA200810226B (en) Crystal structure of CRIg and C3b; CRIg complex

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)